BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit

The Rosen Law Firm is reminding purchasers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025, and February 3, 2026, of the May 4, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Boston Scientific made materially false and misleading statements about the unsustainable growth of its U.S. Electrophysiology segment, leading to investor damages. Investors who bought BSX stock during this period may be entitled to compensation and are encouraged to contact the law firm.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin